In order to provide you with relevant and meaningful content we need to know more about you.
Please choose the category that best describes you.
This content is intended for U.S. Healthcare Professionals. Would you like to proceed?
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
Revised March 2019
Hydromorphone Hydrochloride Injection is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
Hydromorphone Hydrochloride Injection, USP is available as:
Hydromorphone Hydrochloride Injection is contraindicated in patients with:
Hydromorphone Hydrochloride Injection contains hydromorphone, a Schedule II controlled substance. As an...
The following serious adverse reactions are described, or described in greater detail, in other sections:
Table 1 includes clinically significant drug interactions with Hydromorphone Hydrochloride Injection.
Prolonged use of opioid...
Hydromorphone Hydrochloride Injection contains hydromorphone, a Schedule II controlled substance.
Acute overdose with Hydromorphone Hydrochloride Injection can be manifested by respiratory depression...
Hydromorphone Hydrochloride Injection is an opioid agonist, available as an aqueous sterile solution. Each 1 mL of sterile solution contains 1 mg, 2 mg, or 4 mg hydromorphone hydrochloride for use in...
Hydromorphone is a full opioid agonist and is relatively selective for the mµ-opioid receptor, although it can bind...
Safety and Handling Instructions
Access to drugs with a potential for abuse such as Hydromorphone...
Inform patients that opioids could cause a rare but potentially life-threatening...
Instructions for using the Carpuject™ Syringe are available with the reusable Carpuject™ Holder, List 2049-02.
Carpuject™ Single-dose cartridges are to be used ONLY with Carpuject™ Holders, List...
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Contact Medical Information. 8AM-9PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at https://vaers.hhs.gov or call (800) 822-7967.